Evidence map›Paper›PMID 24288430›Full record

ArticleDisease markers2013

Is human papillomavirus associated with prostate cancer survival?

Mariarosa Pascale, Danae Pracella, Renzo Barbazza, Barbara Marongiu, Enrico Roggero, Serena Bonin, Giorgio Stanta

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Early Human Papilloma Virus (HPV) Oncogenic Influences in Breast Cancer.Breast cancer : basic and clinical research · 2015
    Article
  14. Article
  15. Infections and inflammation in prostate cancer.American journal of clinical and experimental urology · 2013
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Mariarosa PascaleOncology Institute of Southern Switzerland (IOSI), Ospedale San Giovanni, 6500 Bellinzona, Switzerland.
Danae Pracella
Renzo Barbazza
Barbara Marongiu
Enrico Roggero
Serena Bonin
Giorgio Stanta
University of Trieste · ITOspedale San Giovanni Bellinzona · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of human papillomavirus (HPV) in prostate carcinogenesis is highly controversial: some studies suggest a positive association between HPV infection and an increased risk of prostate cancer (PCa), whereas others do not reveal any correlation. In this study, we investigated the prognostic impact of HPV infection on survival in 150 primary PCa patients. One hundred twelve (74.67%) patients had positive expression of HPV E7 protein, which was evaluated in tumour tissue by immunohistochemistry. DNA analysis on a subset of cases confirmed HPV infection and revealed the presence of genotype 16. In Kaplan-Meier analysis, HPV-positive cancer patients showed worse overall survival (OS) (median 4.59 years) compared to HPV-negative (median 8.24 years, P = 0.0381). In multivariate analysis age (P < 0.001), Gleason score (P < 0.001), nuclear grading (P = 0.002), and HPV status (P = 0.034) were independent prognostic factors for OS. In our cohort, we observed high prevalence of HPV nuclear E7 oncoprotein and an association between HPV infection and PCa survival. In the debate about the oncogenic activity of HPV in PCa, our results further confirm the need for additional studies to clarify the possible role of HPV in prostate carcinogenesis.

Indexed as

AdenocarcinomaAgedAged, 80 and overCell NucleusHuman papillomavirus 16HumansKaplan-Meier EstimateMaleMiddle AgedMultivariate AnalysisNeoplasm GradingPapillomavirus E7 ProteinsPapillomavirus InfectionsProportional Hazards ModelsProstatic NeoplasmsTissue Array Analysisoncogene protein E7, Human papillomavirus type 16Papillomavirus E7 Proteins

Identifiers

PMID24288430
PMCPMC3830784
OpenAlexW2105779346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.